Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 12 November 2009, doi:10.1136/bmj.b4696
Cite this as: BMJ 2009;339:b4696
Fiona Godlee, editor, BMJ
fgodlee@bmj.com
| The first 150 words of the full text of this article appear below. |
We have two encouraging reports in this weeks BMJ to ward off economic or seasonal gloom. The first is about adult critical care in England. Nearly ten years after a major modernisation and funding initiative led to a 35% increase in staffed beds, Andrew Hutchings and colleagues (doi:10.1136/bmj.b4353) report substantially better processes and lower mortality. They say the initiative has been highly cost effective.
Were going to need good critical care as we in the Northern hemisphere enter our flu season. Were also going to need a good H1N1 vaccine, which brings me to the second encouraging report. In July, the UKs National Institute for Health Research called for proposals to evaluate new variant H1N1 vaccines in children. Instead of the familiar researchers complaint of bureaucratic delay and inefficiency, we have from Andrew Pollard and colleagues (doi:10.1136/bmj.b4652) a story of speed and cooperation. Four weeks after
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?